Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight With Comorbidities”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05869903
What this trial is testing

Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweightOverweight or Obesity
Eli Lilly and Company 3,127
Testing effectiveness (Phase 2)Study completedNCT06595238
What this trial is testing

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
Obesity or Overweight
AstraZeneca 262
Large-scale testing (Phase 3)Looking for participantsNCT06439277
What this trial is testing

Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Who this might be right for
ObesityWeight Gain
Eli Lilly and Company 300
Testing effectiveness (Phase 2)Looking for participantsNCT07752979
What this trial is testing

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweight
AbbVie 360
Testing effectiveness (Phase 2)Study completedNCT01208259
What this trial is testing

The Psychological Treatment of Overweight Binge Eaters Minority Supplement

Who this might be right for
Binge Eating DisorderCognitive Therapy/MethodsMental Disorders/Epidemiology+2 more
Washington University School of Medicine 162
Testing effectiveness (Phase 2)Study completedNCT04881760
What this trial is testing

LY3437943 in Participants Who Have Obesity or Are Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 338
Large-scale testing (Phase 3)Study completedNCT05024032
What this trial is testing

Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)

Who this might be right for
ObesityOverweightMetabolism and Nutrition Disorder
Eli Lilly and Company 210
Not applicableLooking for participantsNCT07439744
What this trial is testing

NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status

Who this might be right for
Obese AdultsMDD
National Science and Technology Council, Taiwan 50
Testing effectiveness (Phase 2)Study completedNCT07281937
What this trial is testing

Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweight
Verdiva Bio Dev Limited 206
Large-scale testing (Phase 3)Looking for participantsNCT07654361
What this trial is testing

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Who this might be right for
ObesityOverweightChronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 3,600
Large-scale testing (Phase 3)Study completedNCT00325546
What this trial is testing

Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)

Who this might be right for
Obesity
Sanofi 643
Large-scale testing (Phase 3)Study completedNCT00386061
What this trial is testing

Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)

Who this might be right for
Obesity
Sanofi 1,507
Large-scale testing (Phase 3)Study completedNCT04657016
What this trial is testing

Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

Who this might be right for
ObesityOverweight
Eli Lilly and Company 579
Not applicableStudy completedNCT03233048
What this trial is testing

Intragastric Balloon in Obese Adolescents With Comorbidities

Who this might be right for
Obesity
Imad Absah 5
Large-scale testing (Phase 3)Study completedNCT00029861
What this trial is testing

Obese Patients With or Without Comorbidities (RIO-North America)

Who this might be right for
ObesityWeight Loss
Sanofi 3,045
Not applicableLooking for participantsNCT07728669
What this trial is testing

Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)Overweight+1 more
Kazakh Academy of Nutrition 120
Not applicableStudy completedNCT05623163
What this trial is testing

Evaluation of Health Improvement in Obese Patients With Obesity-related Comorbidities Followed by EndoZip Procedure

Who this might be right for
Obesity
Nitinotes Surgical Ltd. 38
Not applicableWithdrawnNCT05209997
What this trial is testing

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

Who this might be right for
OverweightObesity
Eurofarma Laboratorios S.A.
Not applicableEnrolling By InvitationNCT07736547
What this trial is testing

AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss

Who this might be right for
Overweight (Without Type 2 Diabetes) With Weight-related ComorbiditiesOverweight (BMI > 25)
Varol TUNALI 80
Large-scale testing (Phase 3)Ended earlyNCT00405808
What this trial is testing

Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose

Who this might be right for
Obesity
Sanofi 2,666
Next Page